Utah Medical Products Inc.

UTMD | NASDAQ

Price Alert Chart Builder DCF Calculator

$76.66

+$2.18 (+2.93%)

Sep 22, 2026, 4:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $237.15M

Enterprise Value $149.81M

Beta 0.36

Average Volume 22.36K

Shares Outstanding (Diluted) 3.18M

Shares Change YoY -1.92%

Institutional Ownership 71.15%

Exchange NASDAQ

ISIN US9174881089

Price Performance

Price Change 1M 4.0%

Price Change 3M 14.2%

Price Change 6M 16.9%

Price Change YTD 31.8%

Price Change 1Y 17.7%

Price Change 3Y -11.6%

Price Change 5Y -21.9%

1M CAGR (ann.) 5.6%

1Y CAGR (ann.) 19.7%

5Y CAGR (ann.) -1.8%

All-Time CAGR 6.5%

Valuation

PE Ratio 22.71

Forward PE N/A

PEG Ratio -1.85

Forward PEG -1.85

PS Ratio 6.57

Forward PS N/A

PB Ratio 1.94

P/FCF Ratio 18.21

P/Adj. FCF Ratio 18.81

P/OCF Ratio 20.02

EV/Sales 4.15

EV/EBIT 12.23

EV/EBITDA 10.21

EV/FCF 11.51

Earnings Yield 4.4%

FCF Yield 5.5%

Adj. FCF Yield 5.3%

Financial Health

Net Cash $87.53M

Total Debt $194K

Cash & Short-Term Investments $87.53M

Total Assets $124.57M

Current Ratio 48.62

Quick Ratio 44.27

Debt / Equity Ratio 0.00

Debt / EBITDA 0.01

Debt / FCF 0.01

OCF / Debt 68.75

Interest Coverage 0.00

Altman Z-Score 57.63

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 54.9%

Operating Profit Margin 28.5%

EBITDA Margin 40.6%

Net Profit Margin 29.0%

FCF Margin 36.1%

Adj. FCF Margin 34.9%

SBC / Revenue 1.1%

SBC Impact (per share) -3.2%

Returns

Return on Assets 8.4%

Return on Equity 8.7%

Return on Invested Capital 6.8%

Return on Capital Employed 8.4%

Return on Tangible Assets 9.5%

Historical Growth (CAGR)

Revenue CAGR 3Y -11.4%

Revenue CAGR 5Y -4.8%

Revenue CAGR 10Y -1.1%

EPS CAGR 3Y -11.6%

EPS CAGR 5Y -1.3%

EPS CAGR 10Y -0.3%

FCF CAGR 3Y -16.5%

FCF CAGR 5Y -7.8%

FCF CAGR 10Y -1.7%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Oct 21, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $53.19

Graham Upside -28.6%

Lynch Fair Value $16.40

Lynch Upside -78.0%

Price Target N/A

Price Target Upside N/A

Cash Flow

Operating Cash Flow $13.34M

Free Cash Flow $13.02M

Adj. Free Cash Flow $12.61M

FCF Per Share $3.60

OCF Per Share $3.72

OCF/S Ratio 32.8%

Income Statement

Revenue $36.11M

Gross Profit $19.82M

Operating Income $10.28M

EBITDA $14.67M

Net Income $10.49M

EPS (Diluted) $3.28

Revenue / Employee $247.31K

Profit / Employee $71.82K

Employees 146

Dividends

Annual Dividend $1.24

Dividend Yield 1.66%

Payout Ratio 37.8%

FCF Payout Ratio 30.4%

Adj. FCF Payout Ratio 31.4%

Dividend Growth (YoY) 1.6%

Pay Frequency Quarterly

Ex-Dividend Date Sep 16, 2026